^
    Apply
    Alvocidib in Combination With Decitabine and Venetoclax in Patients With Relapsed or Refractory AML or as Frontline Therapy in Unfit Patients With AML (NCT04493099)
    Phase 1/2
    M.D. Anderson Cancer Center
    Withdrawn
    Last update posted :
    11/11/2020
    Initiation :
    10/01/2020
    Primary completion :
    10/12/2020
    Completion :
    10/12/2020
    BCL2
    |
    Venclexta (venetoclax) • azacitidine • decitabine • alvocidib (DSP-2033)
    Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell Lymphoma (NCT00005074)
    Phase 2
    NCIC Clinical Trials Group
    Completed
    Last update posted :
    04/09/2020
    Initiation :
    01/24/2000
    Primary completion :
    02/20/2002
    Completion :
    09/22/2008
    CD20 • CD5
    |
    CD20 positive • CD5 positive
    |
    alvocidib (DSP-2033)
    Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors (NCT00957905)
    Phase 2
    National Cancer Institute (NCI)
    Completed
    Last update posted :
    03/10/2017
    Initiation :
    06/01/2009
    Primary completion :
    08/01/2014
    Completion :
    08/01/2014
    AFP
    |
    AFP elevation
    |
    cisplatin • 5-fluorouracil • oxaliplatin • leucovorin calcium • alvocidib (DSP-2033) • fluorouracil topical
    Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT00634244)
    Phase 2
    National Cancer Institute (NCI)
    Completed
    Last update posted :
    07/07/2015
    Initiation :
    10/01/2008
    Primary completion :
    09/01/2014
    Completion :
    10/01/2014
    BCL2
    |
    carboplatin • cytarabine • etoposide IV • sirolimus • mitoxantrone • topotecan • alvocidib (DSP-2033)